-----

Welcome to the November 2012 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, the latest developments from contract manufacturers and fine-chemical producers from CPhI held last month in Madrid. Plus analysis of financing trends from the biotechnology industry. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Global Feature
Contract Manufacturers and Fine-Chemicals Producers Expand
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Fine-chemical manufacturers producers and contract manufacturers announce manufacturing and service expansions at CPhI in Madrid.
>> Read More

Biologics
Mixed Reviews for Biotechnology Financing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Venture-capital funding is up, but initial public offerings still are weak.
>> Read More

Outsourcing
Sizing the Market for Contract Manufacturing
Jim Miller, president of PharmSource Information Services
Measuring the size of the market for contract manufacturing services requires a careful hand.
>> Read More

Formulation
Seeking Solutions in Solid-State Chemistry
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Particle-engineering technologies, such as crystal design for crystallization and producting cocrystals, particle-size reduction, and amorphous solid dispersions, help to optimize delivery of a drug.
>> Read More

CSR and Sustainability Forum
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations. >> Read More

Eli Lilly, Merck Serono, and Astellas Call for Innovation in Global Health
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management .
Pharmaceutical companies and public health officials gather at the IFPMA Assembly to urge for greater innovation and private–public partnerships to address global health concerns. >> Read More

-----

For the full listing of calendar events, see the Calendar of Events page

On-Demand Webcast from Pharmaceutical Technology: Achieving Sensory Benefits and Mildness in Dermatology Products
Leading dermatology companies want topical products that are pleasant to apply while also mitigating irritation, textural features, pain, and itch. Learn from industry experts of the formulation strategies to achieve mildness, mitigate the impact of skin disease, and produce sensorial benefits.Register here